Plasma phthalate levels in pubertal gynecomastia

Pediatrics

Volumn 125, Issue 1, 2010, Pages

  Durmaz, Erdem ^a   Özmert, Elif N ^a   Erkekoǧlu, Pinar ^a   Giray, Belma ^a   Derman, Orhan ^a   Hincal, Filiz ^a   Yurdakök, Kadriye ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Di (2 ethylhexyl) phthalate; Endocrine disrupter; Gynecomastia; Mono (2 ethylhexyl) phthalate; Phthalate; Puberty

Indexed keywords

DI (2 ETHYLHEXYL) PHTHALATE; HORMONE; MONO (2 ETHYLHEXYL) PHTHALATE; PHTHALIC ACID; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GYNECOMASTIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; MALE; PHYSICIAN; PRIORITY JOURNAL; PUBERTAL GYNECOMASTIA; PUBERTY DISORDERS; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CHILD; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL EXPOSURE; GYNECOMASTIA; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PHTHALIC ACIDS; PROBABILITY; PUBERTY; RADIOIMMUNOASSAY; REFERENCE VALUES; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; TURKEY;

EID: 74049107030     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0724     Document Type: Article

References (41)

1. Nydick M, Butos J, Dale JH, Rawson RW. Gynecomastia in adolescent boys. JAMA. 1961;178:449-454
2. Narula HS, Carlson HE. Gynecomastia. Endocrinol Metab Clin N Am. 2007;36:497-519
3. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Diethylphthalate. Atlanta, GA: Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 1995
4. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Di-noctylphthalate. Atlanta, GA: Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 1997
5. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Di-n-butyl Phthalate. Atlanta, GA: Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 2001
6. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Di-(2-ethylhexyl)-phthalate (DEHP). Atlanta, GA: Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 2002
7. US Food and Drug Administration. Safety Assessment of Di-(2-ethylhexyl)-phthalate (DEHP) Released from Medical Devices. Washington, DC: US Food and Drug Administration; 2002. Available at: www.fda.gov/cdrh/ost/dehp-pvc.pdf. Accessed October 21, 2009
8. European Commission Health and Consumer Protection Directorate-General. Opinion on Medical Devices Containing DEHP Plasticized PVC: Neonates and Other Groups Possibly at Risk From DEHP Toxicity. Brussels, Belgium: Scientific Committee on Medical Products and Medical Devices; 2002
9. National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction. Expert Panel Report on Di-(2-ethylhexyl)-phthalate. Alexandria, VA: Science International, Inc; 2000
10. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Di-(2-ethylhexyl)-phthalate. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 1993
11. Shea KM. Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics. 2003;111(6 pt 1):1467-1474
12. Koch HM, Gonzalez-Reche LM, Angerer J. Online cleanup by multidimensional LC-ESIMS/MS for high throughput quantification of primary and secondary phthalate metabolites in human urine. J Chromatogr B. 2003;784:169-182
13. Stroheker T, Cabaton N, Nourdin G, Regnier JF, Lhuguenot JC, Chagnon MC. Evaluation of anti-androgenic activity of di-(2-ethylhexyl)-phthalate. Toxicology. 2005;208(1):115-121
14. Huber WW, Grasl-Kraupp B, Schulte-Hermann R. Hepatocarcinogenic potential of di-(2-ethylhexyl)-phthalate in rodents and its implications on human risk. Crit Rev Toxicol. 1996;26(4):365-481
15. Voss C, Zerban H, Bannasch P, Berger MR. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology. 2005;206(3):359-371
16. Kim Y, Soon YH, Moon A. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells. J Toxicol Environ Health Part A. 2004;67(23-24):2025-2035
17. Hokanson R, Hanneman W, Hennessey M, et al. DEHP, bis(2)-ethylhexyl phthalate, alters gene expression in human cells: possible correlation with initiation of fetal developmental abnormalities. Hum Exp Toxicol. 2006;25(12):687-695
18. US Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry. Toxicological Profile for Di-(2-ethylhexyl)-phthalate. Atlanta, GA: Public Health Service Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services; 2002
19. Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect. 2000;108:895-900
20. Cobellis L, Latin G, DeFelice C, et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod. 2003;18(7):1512-1515
21. Qiao L, Zheng L, Cai D. Study on the di-n-butyl phthalate and di-2-ethylhexyl-phthalate level of girl serum related with precocious puberty in Shanghai. Wei Sheng Yan Jiu. 2007;36(1):93-95
22. Paris I, Ruggieri F, Mazzeo P, Carlucci G. Simultaneous determination of di-(2-ethylhexyl)-phthalate and mono-(2-ethylhexyl)-phthalate in human plasma by HPLC. Anal Lett. 2003;36:2645-2654
23. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672
24. University Hospital of Ghent. Free and bioavailable testosterone calculator. Available at: www.issam.ch/freetesto.htm. Accessed June 15, 2008
25. Kai H, Shono T, Tajiri T, Suita S. Long-term effects of intrauterine exposure to mono-nbutyl phthalate on the reproductive function of postnatal rats. J Pediatr Surg. 2005;40(2):429-433
26. Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DNR, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci. 2000;58(2):350-365
27. Parks LG, Ostby JS, Lambright CR, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci. 2000;58(2):339-349
28. Latini G. The potential hazards of exposure to di-(2-ethylhexyl)- phthalate in babies: a review. Biol Neonate. 2000;78(4):269-276
29. Carruthers CM, Foster PM. Critical window of male reproductive tract development in rats following gestational exposure to di-nbutyl phthalate. Birth Defects Res B Dev Reprod Toxicol. 2005;74(3):277-285
30. Lehmann KP, Phillips S, Sar M, Foster PM, Gaido KW. Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol Sci. 2004;81(1):60-68
31. Thompson CJ, Ross SM, Gaido KW. Di(nbutyl) phthalate impairs cholesterol transport and steroidogenesis in the fetal rat testis through a rapid and reversible mechanism. Endocrinology. 2004;145(3):1227-1237
32. Plonait SL, Nau H, Maier RF, Wittfoht W, Obladen M. Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters. Transfusion. 1993;33(7):598-605
33. Braunstein GD. Clinical practice: gynecomastia. N Engl J Med. 2007;357(12):1229-1237
34. Swan SH, Main KM, Liu F, et al. Study for future families research team: decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056-1061
35. US Department of Health and Human Services, National Toxicology Program, Center for the Evaluation Risks to Human Reproduction. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di-(2-ethylhexyl)-phthalate (DEHP). Bethesda, MD: National Institutes of Health; 2006. National Institutes of Health publication No. 06-4476
36. Koch HM, Preuss R, Angerer J. Di-(2-ethylhexyl)-phthalate (DEHP): human metabolism and internal exposure; an update and latest results. Int J Androl. 2006;29(1):155-165
37. Krüger T, Long M, Bonefeld-Jørgensen EC. Plastic components affect the activation of the aryl hydrocarbon and the androgen receptor. Toxicology. 2008;246(2-3):112-123
38. Moore NP. The oestrogenic potential of the phthalate esters. Reprod Toxicol. 2000;14(3):183-192
39. Blom A, Ekman E, Johannisson A, Norrgren L, Pesonen M. Effects of xenoestrogenic environmental pollutants on the proliferation of a human breast cancer cell line (MCF-7). Arch Environ Contam Toxicol. 1998;34(3):306-310
40. Parker LN, Gray DG, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism. 1986;35(8):705-708
41. Derman O, Kanbur N, Kiliç İ, Kutluk T. Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia. J Pediatr Endocrinol Metabolism. 2008;21:449-453